Chung Yun Soo, Baek Jin Kyung, Choi Euna, Kim Hae-Rim, Kim Heeyon, Lee Yong Jae, Yun Bo Hyon, Seo Seok Kyo
Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Department of Statistics, University of Seoul, Seoul 03722, Republic of Korea.
J Clin Med. 2025 Feb 26;14(5):1550. doi: 10.3390/jcm14051550.
: The prognosis of endometriosis-related ovarian clear cell carcinoma (OCCC) versus non-endometriosis-associated OCCC remains unclear. We examined the impact of endometriosis on OCCC diagnosis and progression and assessed whether prior surgical intervention for endometriotic ovarian cysts affects prognosis. : In this retrospective study (2006-2024), OCCC patients were classified as non-endometriosis-associated or endometriosis-related. A subgroup analysis compared endometriosis-related OCCC patients with and without a history of endometriotic ovarian cyst surgery. : The average CA-125 level was 104.20 (29.90, 347.70) in the non-endometriosis-associated OCCC group and 80.70 (32.40, 247.90) in the endometriosis-related OCCC group ( = 0.32). Early-stage diagnosis occurred in 62.77% and 75.21% of these groups, respectively ( = 0.046). The average age at diagnosis was 53.95 ± 9.71 years for the non-endometriosis-associated group and 45.68 ± 7.98 years for the endometriosis-related group ( < 0.001). Mortality or poor prognosis was observed in 24.11% and 17.80% of these groups, respectively ( = 0.226). In endometriosis-related OCCC, comparisons were made between patients with and without a history of endometriotic ovarian cyst surgery. The average age at diagnosis was 45.84 ± 8.24 years for those without a surgical history and 44.71 ± 6.35 years for those with a surgical history ( = 0.59). Early-stage diagnosis was observed in 77.23% and 62.50%, respectively ( = 0.339). Mortality or poor prognosis occurred in 14.85% of those without a surgical history and 35.29% of those with a surgical history ( = 0.008). The hazard ratio for women with a surgical history was 3.48 (1.29-8.69) ( = 0.008). The incidence rate was 3.17 per 1000 person-years (PYRs) for individuals without surgery and 13.36 per 1000 PYRs for those with a history of surgical intervention ( = 0.008). : Endometriosis did not impact the prognosis of women with OCCC. However, women with endometriosis-related OCCC were diagnosed at earlier stages and at younger ages. A history of endometriotic ovarian cyst surgery did not influence OCCC detection but was linked to poorer survival outcomes.
子宫内膜异位症相关的卵巢透明细胞癌(OCCC)与非子宫内膜异位症相关的OCCC的预后仍不明确。我们研究了子宫内膜异位症对OCCC诊断和进展的影响,并评估了先前针对子宫内膜异位性卵巢囊肿的手术干预是否会影响预后。:在这项回顾性研究(2006 - 2024年)中,OCCC患者被分为非子宫内膜异位症相关或子宫内膜异位症相关。亚组分析比较了有和没有子宫内膜异位性卵巢囊肿手术史的子宫内膜异位症相关OCCC患者。:非子宫内膜异位症相关OCCC组的平均CA - 125水平为104.20(29.90,347.70),子宫内膜异位症相关OCCC组为80.70(32.40,247.90)(P = 0.32)。这些组中早期诊断分别发生在62.77%和75.21%的患者中(P = 0.046)。非子宫内膜异位症相关组的平均诊断年龄为53.95±9.71岁,子宫内膜异位症相关组为45.68±7.98岁(P < 0.001)。这些组中分别有24.11%和17.80%观察到死亡或预后不良(P = 0.226)。在子宫内膜异位症相关OCCC中,对有和没有子宫内膜异位性卵巢囊肿手术史的患者进行了比较。没有手术史的患者平均诊断年龄为45.84±8.24岁,有手术史的患者为44.71±6.35岁(P = 0.59)。早期诊断分别出现在77.23%和62.50%的患者中(P = 0.339)。没有手术史的患者中有14.85%发生死亡或预后不良,有手术史的患者中有35.29%发生(P = 0.008)。有手术史女性的风险比为3.48(1.29 - 8.69)(P = 0.008)。未手术个体的发病率为每1000人年3.17例,有手术干预史的个体为每1000人年13.36例(P = 0.008)。:子宫内膜异位症不影响OCCC女性的预后。然而,子宫内膜异位症相关OCCC的女性诊断时处于更早阶段且年龄更小。子宫内膜异位性卵巢囊肿手术史不影响OCCC的检出,但与较差的生存结果相关。